Company Filing History:
Years Active: 2013
Title: Kevin Tidgewell: Innovator in Cell Proliferative Disorders
Introduction
Kevin Tidgewell is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of pharmaceutical compositions aimed at ameliorating cell proliferative disorders. His innovative work focuses on developing compounds that can effectively treat various diseases, including cancer.
Latest Patents
Kevin Tidgewell holds a patent for "Compositions for ameliorating cell proliferative disorders and methods of making and using them." This patent includes alternative embodiments that provide apratoxin F and apratoxin G compounds, along with their stereoisomers, derivatives, and analogs. The invention outlines pharmaceutical compositions and formulations that can be administered to treat, prevent, and ameliorate diseases characterized by uncontrolled or unwanted cell growth, such as cancer and other hyperproliferative conditions.
Career Highlights
Kevin Tidgewell is affiliated with the University of California, where he continues to advance his research and innovation in the field of pharmaceuticals. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Some of his notable coworkers include William H. Gerwick and Frederick A. Valeriote. Their collaborative efforts contribute to the ongoing research and development of effective treatments for cell proliferative disorders.
Conclusion
Kevin Tidgewell's innovative contributions to the field of pharmaceuticals highlight the importance of research in combating cell proliferative disorders. His work continues to pave the way for advancements in medical treatments.